Concepedia

Edward B. Garon

EB

Statistics

Publications

224

Citations

53.3K

H-Index

73

Active since

2005

Affiliations

University of California, Los Angeles(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Memorial Sloan Kettering Cancer Center

Dana-Farber Cancer Institute

German Center for Lung Research

Edward B. Garon is an author at University of California, Los Angeles specializing in oncology, medicine, and non-small cell lung cancer therapy.

ORCID

Publications per year

2005–2024

224

Publications

224

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder et al. · Science · 2015 · 7.9K citations

, , +17

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2018 · 6.6K citations · Full text

, , +16

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst, Dong‐Wan Kim, Enriqueta Felip et al. · The Lancet · 2015 · 6.5K citations

, , +14

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Edward B. Garon, Naiyer A. Rizvi, Rina Hui et al. · New England Journal of Medicine · 2015 · 6.2K citations · Full text

, , +17

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris, Bruce E. Johnson, Lynne D. Berry et al. · JAMA · 2014 · 1.7K citations

, , +17

1–5 of 224